Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Abingdon Health PLC ( (GB:ABDX) ).
Abingdon Health PLC has successfully raised approximately £3.4 million through a Retail Offer and Placing, issuing new shares at 6 pence each. The funds will support the company’s operations and strategic initiatives, with the new shares expected to commence trading on AIM on 31 October 2025, pending shareholder approval at the upcoming General Meeting. This financial move is poised to strengthen Abingdon Health’s market position and enhance its capabilities in the med-tech industry.
The most recent analyst rating on (GB:ABDX) stock is a Hold with a £7.00 price target. To see the full list of analyst forecasts on Abingdon Health PLC stock, see the GB:ABDX Stock Forecast page.
Spark’s Take on GB:ABDX Stock
According to Spark, TipRanks’ AI Analyst, GB:ABDX is a Neutral.
Abingdon Health PLC’s overall score is driven by its strong business development activities and promising revenue growth, albeit overshadowed by persistent profitability challenges and valuation concerns. Technical indicators suggest a neutral outlook, while recent corporate events present potential for future growth.
To see Spark’s full report on GB:ABDX stock, click here.
More about Abingdon Health PLC
Abingdon Health PLC is a leading med-tech contract service provider, specializing in the development, regulatory support, and manufacturing of rapid diagnostic tests. The company offers comprehensive services including lateral flow product development and technology transfer, catering to a diverse range of sectors such as infectious disease, clinical testing, animal health, and environmental testing. Founded in 2008, Abingdon Health is headquartered in York, England, with additional laboratories in Doncaster, England, and Madison, Wisconsin, USA.
Average Trading Volume: 152,267
Technical Sentiment Signal: Sell
Current Market Cap: £12.1M
Learn more about ABDX stock on TipRanks’ Stock Analysis page.